RioDerm-004 by Rion for Fistula: Likelihood of Approval

RioDerm-004 is under clinical development by Rion and currently in Phase I for Fistula.

Feb 20, 2024 - 18:00

RioDerm-004 is under clinical development by Rion and currently in Phase I for Fistula.

Read the original article

Tags:

Previous Article

Not Disclosed Neurodegeneration by Eli Lilly and Co for Neurodegenerative Diseas...

RioDerm-001 by Rion for Diabetic Foot Ulcers: Likelihood of Approval

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

How did hiring in the Indian pharma industry perform in Q2 2023

How did hiring in the Indian pharma industry perform in...

Jul 29, 2023

Anima Biotech’s machine learning programme ‘reveals new mRNA drug targets’

Anima Biotech’s machine learning programme ‘reveals new...

Oct 10, 2024

MSD sets sights on bispecific antibody market with Curon acqusition

MSD sets sights on bispecific antibody market with Curo...

Aug 11, 2024